Intervention for coronary bifurcation lesion is about 10\~20% of entire percutaneous coronary intervention (PCI). Bifurcation lesion is difficult to be treated and prognosis of PCI at bifurcation lesion has been poorer compared to that at non-bifurcation lesion. Furthermore, occlusion of side branch frequently occurred during PCI. Several techniques to prevent occlusion of side branch have been developed, but outcomes are not to be satisfied. H-side branch stent is developed to treat coronary side branch lesion and composed of proximal, connecting and distal parts. In vivo study performed in pigs showed effective H-side branch stent. This study is to confirm safety and efficacy of H-side branch stent for treatment of coronary side branch lesion.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Implantation of H-side branch stent at coronary bifurcation stenotic lesion
Major adverse cardiovascular events
composite of cardiovascular death, non-fatal myocardial infarction, stent thrombosis, target lesion revascularization
Time frame: During 6 months after implantation of H-side branch stent
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.